Next Article in Journal
“Just Caring”: Can We Afford the Ethical and Economic Costs of Circumventing Cancer Drug Resistance?
Previous Article in Journal
Motivations and Barriers to Sharing Biological Samples: A Case Study
Article Menu

Export Article

Open AccessArticle
J. Pers. Med. 2013, 3(2), 111-123; doi:10.3390/jpm3020111

Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information

Medco Research Institute, LLC, Medco Health Solutions, Inc., Bethesda, MD 20814, USA
EJS Health Solutions, LLC, 1653 Pennfield Drive Thorofare, West Deptford, NJ 08086, USA
Biocerna, LLC, Gaithersburg, MD 20879, USA
Opus Three, LLC, Gaithersburg, MD 20878, USA
Author to whom correspondence should be addressed.
Received: 17 April 2013 / Revised: 24 May 2013 / Accepted: 4 June 2013 / Published: 10 June 2013
View Full-Text   |   Download PDF [427 KB, uploaded 10 June 2013]


We surveyed 10,303 United States physicians on where they obtain pharmacogenomic testing information. Thirty-nine percent indicated that they obtained this from drug labeling. Factors positively associated with this response included older age, postgraduate instruction, using other information sources, regulatory approval/ recommendation of testing, reliance on labeling for information, and perception that patients have benefited from testing. Physicians use pharmacogenomic testing information from drug labeling, highlighting the importance of labeling information that is conducive to practice application.
Keywords: pharmacogenomics; physician; drug labeling; survey pharmacogenomics; physician; drug labeling; survey
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Stanek, E.J.; Sanders, C.L.; Frueh, F.W. Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information. J. Pers. Med. 2013, 3, 111-123.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top